DNA Testing: A Growth Market
DNA technology that can help determine a person's ancestry, predisposition for diseases and possible adverse reactions to drugs has exploded in the past few years, creating a cottage industry of gene-tracing companies that some are comparing to the dotcom boom. "Once these genomic companies get the formula right, they could be very, very successful," says Quintin Lai, senior research analyst at Robert W. Baird & Co.
Mountain View, California-based 23andMe started with seed funding from Google in 2006 and has since become a pioneer in direct-to-consumer genotyping--DNA testing that looks for known markers to reveal information about everything from a person's muscle performance to a possibility that he or she might develop diabetes. Consumers send in saliva and four to six weeks later, log on to a web page with a personalized genetic analysis. "We're confident we will have a viable business," says 23andMe co-founder Linda Avey, 49. "But we're still in startup mode."
Continue reading this article - and everything on Entrepreneur!
Become a member to get unlimited access and support the voices you want to hear more from. Get full access to Entrepreneur for just $5.
Entrepreneur Editors' Picks
-
When Her Parents' Restaurant Burned Down, This First-Generation Founder's Hot Sauce Brand Rose From the Ashes to Take on Corporate Giants
-
Not Hitting Your Goals? Here's How to Know If You Should Change Tactics or Strategy.
-
You Can Generate Your Own Viral LinkedIn Post With This Hilarious Tool
-
This Couple Lost Everything When the Housing Market Crashed. But Manifesting 'Magic' Helped Them Launch a Metaphysical Brand With 10 Stores.
-
The Best Software Solutions and Tech Providers in the Franchising Industry
-
This 18-Year-Old Student Wanted a Better Way to Keep Track of His School Work. So He Built an App — and a Business.
